Everolimus First-line Therapy in Non-rapidly Progressive Castration Resistant Prostate Cancer (CRPC). A Multicenter Phase II Trial.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 May 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 20 Jun 2012 Actual patient number is 37 according to ClinicalTrials.gov.
- 20 Jun 2012 Actual initiation date changed from Aug 2009 to Sep 2009 as reported by ClinicalTrials.gov.